Skip to content

Laughter Yoga- Integrated Virtual Reality Nature Exploration in Early Stage of Chemotherapy

The Effect of Laughter Yoga- Integrated Virtual Reality Nature Exploration on Anxiety and Insomnia of Patients in Early Stage of Chemotherapy

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07798661
Enrollment
60
Registered
2026-09-01
Start date
2026-09-15
Completion date
2027-03-30
Last updated
2026-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patiens in Early Stage of Chemotherapy

Keywords

laughter yoga, anxiety, cancer, chemotherapy, virtual reality, insomnia

Brief summary

After obtaining informed consent, pre-test applications will be performed on participants in the experimental and control groups following randomization, and information regarding treatment plans will be recorded. Patients in the experimental group will receive laughter yoga practice integrated with virtual reality videos during chemotherapy infusion. The practice is planned to be once a week for four weeks. High-resolution, adjustable virtual reality glasses with head and hand tracking features will be used for the virtual reality application. The videos will consist of relaxing content such as nature walks, beach and sea views, and will be prepared in three-dimensional, 360-degree viewing angles integrated with laughter yoga exercises. Personalized video content will be created according to the participants' preferences, and the viewing time will be limited to 10 minutes for each application. After the completion of the fourth course, data collection tools will be re-administered for post-testing purposes.

Interventions

BEHAVIORALlaughter yoga-integrated virtual reality

A digital-based behavioral approach for symptom control

Sponsors

Ataturk University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

≥18 years of age, being in the early stage of chemotherapy, no surgical treatment plan, voluntary participation.

Exclusion criteria

psychiatric disorder, treatments other than chemotherapy, not in the early stage of chemotherapy vision and hearing problems, planned surgical procedure, skin/eye infections that would prevent the use of virtual reality, previous laughter yoga experience.

Design outcomes

Primary

MeasureTime frameDescription
Pittsburgh Sleep Quality Index4 weekThis self-report scale, used to assess sleep quality and sleep-related problems, consists of seven components. The scale was first developed by Buysse et al. in 1989, and studies have shown that it has sufficient internal consistency (Cronbach's alpha=0.80), test-retest reliability, and construct validity. The Turkish validity and reliability study of the scale was carried out by Ağargün et al., and it was shown that it can be used in the Turkish population.
State-Trait Anxiety Inventory (STAI)4 weekDeveloped by Spielberger et al. and adapted into Turkish by Öner and Le Compte, this inventory assesses anxiety levels. It includes two subscales, each consisting of 20 items, measuring the individual's immediate anxiety level and general anxiety tendency separately. The scale is evaluated on a four-point Likert scale, with scores ranging from 20 to 80, indicating a higher level of anxiety.

Countries

Turkey (Türkiye)

Contacts

CONTACTyasemin Ciraci, Assist. Prof.
yaseminciraci90@gmail.com00904422311448

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 2, 2026